Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it will
participate at the 20th Annual London Spine Course Conference from Wednesday,
June 25th to Friday, June 27th, 2014, at the Royal College of Surgeons of
England in London, United Kingdom, Booth #19. 


"As a global medical device company, we look forward to presenting at the 20th
Annual London Spine Course to share our newest game changing products," said
Trent Northcutt, President and CEO of Aurora Spine. "Since Aurora Spine has
introduced its screw-less spine portfolio with a revolutionary minimally
disruptive approach, patients no longer have to undergo invasive spine
procedures. Patients are often able to walk the same day of surgery, experience
less blood loss, and spend less time in the hospital which helps the speed of
the patient's recovery time. We are very excited to participate at London Spine
to showcase the ZIP Ultra(TM) and our entire portfolio of solutions for the
spine."


About Aurora Spine 

Aurora Spine is an early stage company focused on bringing new solutions to the
spinal implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.


Forward-Looking Statements 

This news release contains forward-looking information that involves substantial
known and unknown risks and uncertainties, most of which are beyond the control
of Aurora Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking information").
Forward-looking information in this news release includes information concerning
the growth potential of Aurora Spine's products. Aurora Spine cautions investors
of its securities about important factors that could cause Aurora Spine's actual
results to differ materially from those projected in any forward-looking
statements included in this news release. Any statements that express, or
involve discussions as to, expectations, beliefs, plans, objectives, assumptions
or future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and uncertainties which
could cause actual results or outcomes to differ unilaterally from those
expressed in such forward-looking statements. No assurance can be given that the
expectations set out herein will prove to be correct and, accordingly,
prospective investors should not place undue reliance on these forward looking
statements. These statements speak only as of the date of this press release and
Aurora Spine does not assume any obligation to update or revise them to reflect
new events or circumstances. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004


Aurora Spine Corporation
Eric Fronk
Chief Financial Officer
(760) 424-2004

Aurora Spine (TSXV:ASG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Aurora Spine 차트를 더 보려면 여기를 클릭.
Aurora Spine (TSXV:ASG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Aurora Spine 차트를 더 보려면 여기를 클릭.